High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy
出版年份 2013 全文链接
标题
High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy
作者
关键词
-
出版物
MODERN PATHOLOGY
Volume 27, Issue 1, Pages 96-106
出版商
Springer Nature
发表日期
2013-07-26
DOI
10.1038/modpathol.2013.127
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer
- (2013) L. Burkhardt et al. CANCER RESEARCH
- Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions
- (2013) Martina Kluth et al. MODERN PATHOLOGY
- Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
- (2012) Antje Krohn et al. AMERICAN JOURNAL OF PATHOLOGY
- Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades
- (2012) Jonathan I. Epstein et al. EUROPEAN UROLOGY
- Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression inERG-fusion-positive cancers
- (2012) Julia Müller et al. INTERNATIONAL JOURNAL OF CANCER
- Nuclear karyopherin a2: a novel biomarker for infiltrative astrocytomas
- (2012) K. Gousias et al. JOURNAL OF NEURO-ONCOLOGY
- Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence
- (2012) Katharina Grupp et al. MODERN PATHOLOGY
- Marked heterogeneity of ERG expression in large primary prostate cancers
- (2012) Sarah Minner et al. MODERN PATHOLOGY
- TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling
- (2011) Jan C Brase et al. BMC CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Detection ofERGgene rearrangements andPTENdeletions in unsuspected prostate cancer of the transition zone
- (2011) Shuhong Liu et al. CANCER BIOLOGY & THERAPY
- Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways
- (2011) H.-F. Yuen et al. CLINICAL CANCER RESEARCH
- KPNA2 Expression Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy
- (2011) A. Mortezavi et al. CLINICAL CANCER RESEARCH
- ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy
- (2011) Sarah Minner et al. CLINICAL CANCER RESEARCH
- The genomic complexity of primary human prostate cancer
- (2011) Michael F. Berger et al. NATURE
- Nuclear transport receptor karyopherin-α2 promotes malignant breast cancer phenotypes in vitro
- (2011) E Noetzel et al. ONCOGENE
- Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness
- (2011) S Huang et al. ONCOGENE
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- FZD4 as a Mediator of ERG Oncogene-Induced WNT Signaling and Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells
- (2010) S. Gupta et al. CANCER RESEARCH
- Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome
- (2010) Chun-I. Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Overexpression of Karyopherin-2 in Epithelial Ovarian Cancer and Correlation With Poor Prognosis
- (2010) Min Zheng et al. OBSTETRICS AND GYNECOLOGY
- High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer
- (2010) Sarah Minner et al. PROSTATE
- Overexpression of Prostate-Specific TMPRSS2(exon 0)-ERG Fusion Transcripts Corresponds with Favorable Prognosis of Prostate Cancer
- (2009) K. G. Hermans et al. CLINICAL CANCER RESEARCH
- Chromosome 8p Deletions and 8q Gains are Associated with Tumor Progression and Poor Prognosis in Prostate Cancer
- (2009) A. T. El Gammal et al. CLINICAL CANCER RESEARCH
- Activation of the Ran GTPase Is Subject to Growth Factor Regulation and Can Give Rise to Cellular Transformation
- (2009) Thi K. Ly et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
- (2009) Brett S Carver et al. NATURE GENETICS
- Wnt Signaling from Development to Disease: Insights from Model Systems
- (2009) K. M. Cadigan et al. Cold Spring Harbor Perspectives in Biology
- Integration ofERGgene mapping and gene-expression profiling identifies distinct categories of human prostate cancer
- (2008) Sameer Jhavar et al. BJU INTERNATIONAL
- Nuclear karyopherin α2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity
- (2008) Oleg Gluz et al. INTERNATIONAL JOURNAL OF CANCER
- Structural basis for the nuclear import of the human androgen receptor
- (2008) M. L. Cutress et al. JOURNAL OF CELL SCIENCE
- Clinical significance of p53 alterations in surgically treated prostate cancers
- (2008) Thorsten Schlomm et al. MODERN PATHOLOGY
- Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer
- (2008) Scott A. Tomlins et al. NEOPLASIA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started